The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Supprelin La
histrelin acetate · HISTRELIN ACETATE 50 mg/1 · Implant · Subcutaneous · Endo USA, Inc.
NDC 67979-0002-01 · 1 VIAL, GLASS in 1 CARTON / 1 IMPLANT in 1 VIAL, GLASS · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$48,767.37
Reported to Texas DSHS · 2025 annual filing · Endo USA, Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 50 MG
$37491.974
HCPCS J9226 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$3.4M
86 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA022058
- TE code
- —
- Approval date
- May 3, 2007
- Patents / exclusivity
- 1 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 8062652 | Jun 16, 2026 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of histrelin acetate (Implant)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Endo USA, Inc. | HISTRELIN ACETATE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Supprelin La — NDC 67979-0002-01," retrieved September 3, 2026, https://drugdashboards.com/drug/67979000201.
Free to cite with attribution — see how the data is put together.